Gland Pharma Ltd. (GLAND): Gland Pharma Share Price rises 2.02% as stock gains today

Published: 18 September 2026 at 9:49:48 AM IST

Gland Pharma Share Price moved higher today, with the stock at Rs 2,969.35 after a 2.02% rise from the previous close of Rs 2,910.65. The company’s market capitalisation now stands at Rs 46,684.87 crore. In a session that also saw the day’s open at Rs 2,904.05 and an intraday high of Rs 2,978.85, the move keeps Gland Pharma Ltd. in focus across Gland Pharma Share Price Today, Gland Pharma Stock News and broader Indian Stock Market tracking. The available data confirms the price event, while no company-specific catalyst is established in the supplied figures.

The day’s turnover of Rs 2.17 crore shows the traded value associated with the session, but it does not by itself explain the move. For readers following Gland Pharma Share Price, the most useful context today is the combination of a positive close, a market cap above Rs 46,000 crore, and valuation metrics that can be compared with sector benchmarks in Healthcare and Pharmaceuticals & Drugs. Univest is tracking the stock with a focus on factual price action, fundamentals and peer context.

Gland Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,969.35
Previous Close	Rs 2,910.65
Today's Move	Rs 58.7 (+2.02%)
Open	Rs 2,904.05
High	Rs 2,978.85
Low	Rs 2,904.05
Turnover	Rs 2.17 crore
Market Capitalisation	Rs 46,684.87 crore
Market Cap Category	Large Cap

Gland Pharma Ltd. (GLAND) rose to Rs 2,969.35 from the previous close of Rs 2,910.65, a move of Rs 58.7 or 2.02%. The stock opened at Rs 2,904.05, reached a high of Rs 2,978.85, recorded a low of Rs 2,904.05.

Gland Pharma Share Price Today ended at Rs 2,969.35, up Rs 58.70 or 2.02% from the previous close of Rs 2,910.65. The stock opened at Rs 2,904.05, matched its low at Rs 2,904.05, and reached a day high of Rs 2,978.85. The session therefore stayed within a relatively narrow band around the higher end of the day’s range. The move confirms a share price gain on the day, and the supplied data shows the event clearly without establishing a company-specific trigger. For Gland Pharma Stock News readers, this is a straightforward price update rather than a causation-led story. Univest is presenting the verified market move, the open-high-low pattern and the turnover of Rs 2.17 crore as the factual session backdrop.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 46,684.87 crore
P/E Ratio	42.55x
P/B Ratio	4.52x
ROE	10.56%
ROCE	14.96%
EPS	Rs 68.41
Book Value Per Share	Rs 644.16
Dividend Yield	0.69%

Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 42.55x, P/B 4.52x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.

Gland Pharma Ltd. has a market capitalisation of Rs 46684.87 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.55x, P/B at 4.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.69%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.55x
Benchmark Median P/E	32.69x
Benchmark Average P/E	44.72x
Benchmark P/E Range	3.44x to 417.17x
Company P/B Ratio	4.52x
Benchmark Median P/B	3.1x
Company ROE	10.56%
Benchmark Median ROE	11.78%
Company ROCE	14.96%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 46,684.87 crore
Benchmark Median Market Cap	Rs 741.38 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.55x, which is above the benchmark median of 32.69x, a difference of +30.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.78%, a difference of -10.36%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.65%, a difference of +9.6%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	37.01	5.18	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,44,223.13	84.83	14.05	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,83,453.32	85.3	20.73	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,10,224.17	25.14	4.21	19.69	21.39
Cipla Ltd.	CIPLA	1,09,848.55	32.89	3.15	11.83	16

Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.55x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.56% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 46,684.87 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma

• Gland Pharma Share Price rose 2.02% today to Rs 2,969.35, after closing above the previous close of Rs 2,910.65.
• The day’s range ran from Rs 2,904.05 to Rs 2,978.85, showing where the stock traded during the session.
• Market capitalisation stands at Rs 46,684.87 crore, which is the main size metric in today’s Gland Pharma Stock News.
• P/E is 42.55 and P/B is 4.52, placing valuation above the benchmark median on both measures.
• ROE is 10.56% and ROCE is 14.96%, giving Gland Pharma Fundamental Analysis a mixed but measurable profitability context.

About Gland Pharma

Gland Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data positions the company within a large listed universe of peer pharmaceutical businesses and allows comparison on valuation, profitability and market capitalisation. Gland Pharma Share Price readers typically look at this name in the context of company financials, sector trends and peer benchmarking rather than on a single headline metric.

From the available figures, the business can be described through its market profile and financial ratios: Rs 46,684.87 crore market capitalisation, P/E of 42.55, P/B of 4.52, ROE of 10.56%, ROCE of 14.96%, EPS of Rs 68.41, book value of Rs 644.16 and dividend yield of 0.69%. That profile helps explain why Gland Pharma Share Price remains part of regular Gland Pharma Stock Analysis and Gland Pharma Latest News coverage on Univest. The company is also tracked against Healthcare sector peers for valuation and performance context.

Track Gland Pharma Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Gland Pharma Share Price on Univest for live updates on price movement, valuation ratios, sector comparison, shareholding pattern, 52-week levels and market insights. Univest brings Gland Pharma Share Price Today, Gland Pharma Stock News and Gland Pharma Fundamental Analysis into one place for quick monitoring. Investors can also follow the company page for consolidated market data and regular stock updates.

Frequently Asked Questions

Why did Gland Pharma Share Price rise today?

Ans. Gland Pharma Share Price rose 2.02% to Rs 2,969.35. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 2,910.65.

What is Gland Pharma Share Price Today?

Ans. Gland Pharma Share Price Today is Rs 2,969.35. It was above the previous close of Rs 2,910.65 and finished Rs 58.70 higher on the session. The previous close was Rs 2,910.65.

What is the market capitalisation of Gland Pharma?

Ans. Gland Pharma’s market capitalisation stands at Rs 46,684.87 crore. That places it well above the same-industry median and average shown in the supplied benchmark set. The company operates in the Healthcare sector.

What do Gland Pharma valuation ratios show?

Ans. Gland Pharma has a P/E of 42.55 and a P/B of 4.52. Both sit above the benchmark median, while ROE and ROCE provide a profitability context for comparison. The company trades at a P/E ratio of 42.55x.

How does Gland Pharma compare with peers?

Ans. Gland Pharma is smaller than Sun Pharma, Divi’s and Torrent on market cap, but larger than Zydus and Cipla in the supplied peer set. Its P/E is below several high-multiple peers.